l-Phenylalanine ammonia-lyase (PAL, EC 18.104.22.168) from Rhodosporidium toruloides was utilized to remove l-phenylalanine (l-Phe) from different commercial protein hydrolysates. A casein acid hydrolysate (CAH, l-Phe ~2.28 %) was employed as a model substrate. t-Cinnamic acid resulting from deamination of l-Phe was extracted, analyzed at λ = 290 nm, and used for PAL activity determination. Optimum reaction conditions, optimized using successive Doehlert design, were 35 mg mL−1 of CAH and 800 mU mL−1 of PAL, while temperature and pH were 42 °C and 8.7, respectively. Reaction kinetics of PAL with CAH was determined under optimized conditions. Then, removal of l-Phe from CAH was tested. Results showed that more than 92 % of initial l-Phe was eliminated. Similar results were obtained with other protein hydrolysates. These findings demonstrate that PAL is a useful biocatalyst for l-Phe removal from protein hydrolysates, which can be evaluated as potential ingredients in foodstuffs for PKU patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Adachi O, Matsushita K, Shinagawa E, Ameyama M (1990) Crystallization and properties of l-phenylalanine ammonia-lyase from Rhodosporidium toruloides. Agric Biol Chem 54:2839–2843
Aguiar A, Ahring K, Almeida MF, Assoun M, Belanger Quintana A et al (2015) Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach. Mol Genet Metab 115:17–22
Ambrus CM, Sharma SD, Horvath C, Kalghatgi K, Anthone S, Ambrus JL, Cooley C, Mirand EA (1983) In vivo safety of hollow fiber enzyme reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria. J Pharmacol Exp Ther 224:598–602
Ambrus CM, Anthone S, Horvath C, Kalghatgi K, Lele AS, Eapen G, Ambrus JL, Ryan AJ, Li P (1987) Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria. Ann Intern Med 106:531–537
Ateş S, Doǧan NS (2010) Properties of immobilized phenylalanine ammonia lyase and investigation of its use for prediagnosis of phenylketonuria. Turk J Biochem 35:58–62
Atherton ND, Green A (1988) HPLC measurement of phenylalanine in plasma. Clin Chem 34:2241–2244
Borrajo GJC (2012) Panorama epidemiológico de la fenilcetonuria (PKU) en Latinoamérica. Acta Pediatr Mex 33:279–287
Campistol J, Gassió R, Artuch R, Vilaseca MA (2011) Neurocognitive function in mild hyperphenylalaninemia. Dev Med Child Neurol 53:405–408
Cleary MA (2015) Phenylketonuria. Paediatrics and Child Health 25:108–112
Courtney-Martin G, Bross R, Raffi M, Clarke JTR, Ball RO, Pencharz PB (2002) Phenylalanine requirement in children with classical PKU determined by indicator amino acid oxidation. Am J Physiol Endocrinol Metab 283:E1249–E1256
Doehlert DH (1970) Uniform shell designs. Appl Stat 19:231–239
D`Cunha GB, Satyanarayan V, Nair PM (1996) Purification of phenylalanine ammonia lyase from Rhodotorula glutinis. Phytochemistry 42:17–20
Feillet F, van Spronsen FJ, MacDonald A, Trefz FK, Demirkol M, Giovannini M, Bélanger-Quintana A, Blau N (2010) Challenges and pitfalls in the management of phenylketonuria. Pediatrics 126:333–341
Fritz RR, Hodgins DS, Abell CW (1976) Phenylalanine ammonia-lyase: induction and purification from yeast and clearance in mammals. J Biol Chem 251:4646–4650
Havir EA, Hanson KR (1968) l-Phenylalanine ammonia-lyase. I. Purification and molecular size of the enzyme from potato tubers. Biochemistry 7:1896–1903
Hodgins DS (1971) Yeast phenylalanine ammonia-lyase: purification, properties, and the identification of catalytically essential dehydroalanine. J Biol Chem 246:2977–2985
Kim W, Erlandsen H, Surendran S, Stevens RC, Gamez A, Michols-Matalon K, Tyring SK, Matalon R (2004) Trends in enzyme therapy for phenylketonuria. Mol Ther 10:220–224
Koukol J, Conn EE (1961) The metabolism of aromatic compounds in higher plants IV. Purification and properties of the phenylalanine deaminase of Hordeum vulgare. J Biol Chem 236:2692–2698
Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, Sakamoto O, Fujü K, Matsubara Y, Narisawa K (1999) Tetrahydrobiopterin-responsive phenylalanine hydroxilase deficiency. J Pediatr 135:375–378
Longo N, Harding CO, Burton BK, Grange DK, Vochley J, Wasserstein M, Rice GM, Dorenbaum A, Neuenburg JK, Musson DG, Gu Z, Sile S (2014) Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial. Lancet 384:37–44
Ney DM, Gleason ST, van Calcar SC, MacLeod EL, Nelson KL, Etzel MR, Rice GM, Wolff JA (2009) Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis 32(1):32–39
Ogata K, Uchiyama K, Yamada H (1966) Microbial formation of cinnamic acid from phenylalanine. Agric Biol Chem 30:311–312
Ogata K, Uchiyama K, Yamada H (1967) Metabolism of aromatic amino acid in microorganisms: part I. Formation of cinnamic acid from phenylalanine. Agric Biol Chem 31:200–206
Sarkissian CN, Gámez A, Wang L, Charbonneau M, Fitzpatrick P, Lemontt JF, Zhao B, Vellard M, Bell SM, Henschell C, Lambert A, Tsuruda L, Stevens RC, Scriver CR (2008) Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria. PNAS 105:20894–20899
Soltanizadeh N, Mirmoghtadaie L (2014) Strategies used in production of phenylalanine-free foods for PKU management. Compr Rev Food Sci F 13:287–299
van Spronsen FJ, de Groot MJ, Hoeksma M, Reijngoud DJ, van Rijn M (2010) Large neutral amino acids in the treatment of PKU: from theory to practice. J Inherit Metab Dis 33:671–676
Vockley J, Andersson HC, Antshel KM, Braverman NE, Burton BK, Frazier DM, Mitchell J, Smith WE, Thompson BH, Berry SA (2014) Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med 16:188–200
Whetten RW, Sederoff RR (1991) Phenylalanine ammonia-lyase from loblolly pine: purification of the enzyme and isolation of complementary DNA clones. Plant Physiol 98:380–386
Williams RA, Mamotte CDS, Burnett JR (2008) Phenylketonuria: an inborn error of phenylalanine metabolism. Clin Biochem Rev 29:31–41
Yamada S, Nabe K, Izuo N, Nakamichi K, Chibata I (1981) Production of l-phenylalanine from trans-cinnamic acid with Rhodotorula glutinis containing l-phenylalanine ammonia-lyase activity. Appl Environ Microbiol 42:773–778
This research was supported by grants from the Argentina National Research Council (CONICET, PIP 0662), the National University of La Plata (UNLP, 11/X650), and the National Technological University (UTN, 25/I060). In addition, a part of this work was supported by FY 2011-2013 Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science KAKENHI 23580135 to O. Adachi. Authors extend their appreciation to Ms. Alicia María Noceti and Dr. Gustavo J. C. Borrajo for their assistance.
This paper is dedicated to the memory of our dear colleague, Prof. Carlos F. Mignone, who recently passed away.
About this article
Cite this article
Castañeda, M.T., Adachi, O. & Hours, R.A. Reduction of l-phenylalanine in protein hydrolysates using l-phenylalanine ammonia-lyase from Rhodosporidium toruloides . J Ind Microbiol Biotechnol 42, 1299–1307 (2015). https://doi.org/10.1007/s10295-015-1664-z
- Phenylalanine ammonia-lyase
- Rhodosporidium toruloides
- Casein acid hydrolysate
- l-Phe removal